Pediatric Thromboembolism Differential Diagnoses
- Author: Scott C Howard, MD; Chief Editor: Robert J Arceci, MD, PhD more...
Because thromboembolism is uncommon and its symptoms are often nonspecific in children, a high index of suspicion is required. Conditions to consider in the differential diagnosis of thromboembolism include the following:
- Vasculitis and Thrombophlebitis
- Congenital heart disease
- Neoplasm of the CNS
Askegard-Giesmann JR, O'Brien SH, Wang W, Kenney BD. Increased use of enoxaparin in pediatric trauma patients. J Pediatr Surg. 2012 May. 47(5):980-3. [Medline].
Nuss R, Hays T, Chudgar U, et al. Antiphospholipid antibodies and coagulation regulatory protein abnormalities in children with pulmonary emboli. J Pediatr Hematol Oncol. 1997 May-Jun. 19(3):202-7. [Medline].
Goldenberg NA, Bernard TJ. Venous thromboembolism in children. Pediatr Clin North Am. 2008 Apr. 55(2):305-22, vii. [Medline].
Sandoval JA, Sheehan MP, Stonerock CE, Shafique S, Rescorla FJ, Dalsing MC. Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk. J Vasc Surg. 2008 Apr. 47(4):837-43. [Medline].
Gruenwald CE, Manlhiot C, Abadilla AA, Kwok J, Maxwell S, Holtby HM, et al. Heparin brand is associated with postsurgical outcomes in children undergoing cardiac surgery. Ann Thorac Surg. 2012 Mar. 93(3):878-82. [Medline].
Kosch A, Koch HG, Heinecke A, et al. Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thromb Haemost. 2004. 91(2):308-14. [Medline].
Altinisik J, Ates O, Ulutin T, et al. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients. Clin Appl Thromb Hemost. 2008 Oct. 14(4):415-20. [Medline].
Yamamura K, Joo K, Ohga S, Nagata H, Ikeda K, Muneuchi J, et al. Thrombocytosis in asplenia syndrome with congenital heart disease: A previously unrecognized risk factor for thromboembolism. Int J Cardiol. 2012 Jun 22. [Medline].
Stein PD, Kayali F, Olson RE. Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr. 2004. 145(4):563-5. [Medline].
Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 2009 Oct. 124(4):1001-8. [Medline]. [Full Text].
Nowak-Gottl U, Kosch A. Factor VIII, D-Dimer, and thromboembolism in children. N Engl J Med. 2004 Sep 9. 351(11):1051-3. [Medline].
Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med. 2004 Sep 9. 351(11):1081-8. [Medline].
Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994 Mar 1. 83(5):1251-7. [Medline].
Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res. 2000 Jun. 47(6):763-6. [Medline].
Kuhle S, Koloshuk B, Marzinotto V, et al. A cross-sectional study evaluating post-thrombotic syndrome in children. Thromb Res. 2003. 111(4-5):227-33. [Medline].
Athale U, Siciliano S, Thabane L, Pai N, Cox S, Lathia A. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer. 2008 Dec. 51(6):792-7. [Medline].
Athale UH, Nagel K, Khan AA, Chan AK. Thromboembolism in children with lymphoma. Thromb Res. 2008. 122(4):459-65. [Medline].
Biss TT, Brandao LR, Kahr WH, Chan AK, Williams S. Clinical features and outcome of pulmonary embolism in children. Br J Haematol. 2008 Sep. 142(5):808-18. [Medline].
Monagle P, Chan AK, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb. 141(2 Suppl):e737S-801S. [Medline]. [Full Text].
Lidegaard O, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ. 2011 Oct 25. 343:d6423. [Medline]. [Full Text].
Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood. 2007 Mar 15. 109(6):2419-23. [Medline].
Aissaoui N, Martins E, Mouly S, Weber S, Meune C. A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both. Int J Cardiol. 2009 Sep 11. 137(1):37-41. [Medline].
Massicotte P, Julian JA, Gent M, et al. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res. 2003. 109(2-3):85-92. [Medline].
Skinner R, Koller K, McIntosh N, McCarthy A, Pizer B. Prevention and management of central venous catheter occlusion and thrombosis in children with cancer. Pediatr Blood Cancer. 2008 Apr. 50(4):826-30. [Medline].
Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun. 133(6 Suppl):887S-968S. [Medline].
Agnelli G, Verso M. Epidemiology of cerebral vein and sinus thrombosis. Front Neurol Neurosci. 2008. 23:16-22. [Medline].
Aissaoui N, Martins E, Mouly S, et al. A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both. Int J Cardiol. 2008 Aug 6. [Medline].
Akl EA, Rohilla S, Barba M, et al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review. Cancer. 2008 Oct 1. 113(7):1685-94. [Medline].
Alioglu B, Avci Z, Tokel K, et al. Thrombosis in children with cardiac pathology: analysis of acquired and inherited risk factors. Blood Coagul Fibrinolysis. 2008 Jun. 19(4):294-304. [Medline].
Athale U, Siciliano S, Thabane L, et al. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer. 2008 Dec. 51(6):792-7. [Medline].
Babyn PS, Gahunia HK, Massicotte P. Pulmonary thromboembolism in children. Pediatr Radiol. 2005 Mar. 35(3):258-74. [Medline].
Barnes C, Newall F, Ignjatovic V, et al. Reduced bone density in children on long-term warfarin. Pediatr Res. 2005. 57(4):578-81. [Medline].
Billett HH. Antiplatelet agents and arterial thrombosis. Cardiol Clin. 2008 May. 26(2):189-201, vi. [Medline].
Dentali F, Gianni M, Agnelli G, et al. Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis. J Thromb Haemost. 2008 Jan. 6(1):70-5. [Medline].
Faustino EV, Hanson S, Spinella PC, Tucci M, O'Brien SH, Nunez AR, et al. A multinational study of thromboprophylaxis practice in critically ill children. Crit Care Med. 2014 May. 42(5):1232-40. [Medline].
Gist KM, Chima RS. The landscape of thromboprophylaxis utilization in critically ill children: sparse and variable. Crit Care Med. 2014 May. 42(5):1317-8. [Medline].
Goldenberg NA, Everett AD, Graham D, Bernard TJ, Nowak-Göttl U. Proteomic and other mass spectrometry based "omics" biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: Current state, unmet needs, and future directions. Proteomics Clin Appl. 2014 Dec. 8(11-12):828-36. [Medline].
Journeycake JM, Manco-Johnson MJ. Thrombosis during infancy and childhood: what we know and what we do not know. Hematol Oncol Clin North Am. 2004. 18(6):1315-38, viii-ix. [Medline].
Male C, Chait P, Ginsberg JS, et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thromb Haemost. 2002. 87(4):593-8. [Medline].
Morgan J. Perioperative venous thrombosis in children: is it time for primary prophylaxis?. Paediatr Anaesth. 2007 Feb. 17(2):99-101. [Medline].
Price VE, Chan AK. Arterial thrombosis in children. Expert Rev Cardiovasc Ther. 2008 Mar. 6(3):419-28. [Medline].
Price VE, Chan AK. Venous thrombosis in children. Expert Rev Cardiovasc Ther. 2008 Mar. 6(3):411-8. [Medline].
Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood. 1999. 94(9):3007-14. [Medline].
van Beynum IM, Smeitink JA, den Heijer M, et al. Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation. 1999 Apr 27. 99(16):2070-2. [Medline].
Vidal E, Sharathkumar A, Glover J, Faustino EV. Central venous catheter-related thrombosis and thromboprophylaxis in children:a systematic review and meta-analysis. J Thromb Haemost. 2014 May 6. [Medline].
Vu LT, Nobuhara KK, Lee H, et al. Determination of risk factors for deep venous thrombosis in hospitalized children. J Pediatr Surg. 2008 Jun. 43(6):1095-9. [Medline].
Wasay M, Dai AI, Ansari M, et al. Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States. J Child Neurol. 2008 Jan. 23(1):26-31. [Medline].
Young G, Albisetti M, Bonduel M, et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation. 2008 Sep 23. 118(13):1373-82. [Medline].
Young G, Manco-Johnson M, Gill JC, et al. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost. 2003 May. 1(5):958-62. [Medline].